Cargando…
BAY 11-7082 Is a Broad-Spectrum Inhibitor with Anti-Inflammatory Activity against Multiple Targets
BAY 11-7082 (BAY) is an inhibitor of κB kinase (IKK) that has pharmacological activities that include anticancer, neuroprotective, and anti-inflammatory effects. In this study, BAY-pharmacological target pathways were further characterized to determine how this compound simultaneously suppresses var...
Autores principales: | Lee, Jaehwi, Rhee, Man Hee, Kim, Eunji, Cho, Jae Youl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382285/ https://www.ncbi.nlm.nih.gov/pubmed/22745523 http://dx.doi.org/10.1155/2012/416036 |
Ejemplares similares
-
In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri
por: Debnath, Anjan, et al.
Publicado: (2018) -
Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082
por: Pustchi, Sadaf E., et al.
Publicado: (2020) -
Effects of the NF-κB Signaling Pathway Inhibitor BAY11-7082 in the Replication of ASFV
por: Gao, Qi, et al.
Publicado: (2022) -
Synergistic inhibition of lung cancer cells by EGCG and NF-κB inhibitor BAY11-7082
por: Zhang, Lingyu, et al.
Publicado: (2019) -
The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system
por: Strickson, Sam, et al.
Publicado: (2013)